Healthcare Pharmaceutical Biotech

Aetna Announces Progress on Industry Leading Efforts To Simplify Prior Authorization

April 27, 2026 9:00 AM

Originally published on CVS Health Company News Aetna®, a CVS Health® company (NYSE:CVS), is setting the pace for prior authorization reform, moving faster and further to simplify access to care for patients and providers. Aetna announced the company has already standardized 88% of its prior authorization volume, exceeding industry commitments, and continues to maintain the fewest medical services requiring prior authorization among national...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Generates Over $200,000 in Capital Through Infinite Auctions, Accelerating AI Platform Growth

April 27, 2026 8:35 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced that its subsidiary, Infinite Auctions, has generated over $200,000 in capital through the successful sale of company-owned inventory, including high-end sports cards and historically significant game-worn memorabilia. The Company intends to deploy these proceeds toward accelerating growth initiatives across its expanding artificial intelligence platform, with an...

Read more

Aspire Biopharma Announces $5.0 Million Share Repurchase Program

April 27, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that its Board of Directors (the "Board") has authorized the repurchase of up to $5.0 million of the Company's common stock. The authorization reflects the Board's confidence in the Company's balance sheet strength, the value of its drug development pipeline and...

Read more

Trump Psychedelic Executive Order Accelerates Industry Growth

April 27, 2026 8:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator focused on scalable production of functional and psychoactive mushroom ingredients, today announced that it is uniquely positioned to benefit from the recent executive order signed by Donald Trump to accelerate research, development, and regulatory review of psychedelic therapies for mental health disorders. The executive order is designed to fast-track clinical research and expand access...

Read more

ASMED Hair Transplant Announces Availability of Long Hair FUE Procedure Without Head Shaving

April 27, 2026 6:30 AM

ASMED Hair Transplant announces the availability of the Long Hair FUE procedure, a hair transplantation method performed without shaving the donor or recipient areas. The procedure is now part of the clinical service portfolio at the medical center. The Long Hair FUE technique involves extraction of donor grafts while maintaining full hair length, followed by implantation into areas experiencing thinning or hair loss. The process follows the...

Read more

Who Does the Best Thigh Lift in Florida?

April 27, 2026 6:00 AM

Interest in body contouring continues to rise as patients are actively looking for procedures that addresses excess skin, improve leg contours, and create more beautiful lower body looks. Among body contouring options, thigh lift surgery remains one of the most effective procedures for reshaping the inner and outer thighs, especially after weight loss or age-related skin laxity. In Florida, where cosmetic surgery is highly competitive, surgeon...

Read more

Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML

April 27, 2026 1:20 AM

Cantargia AB (Nasdaq Stockholm:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today announced early results from the ongoing Phase 1b/2a clinical trial evaluating nadunolimab in combination with azacitidine in high-risk myelodysplastic syndrome (MDS), or in combination with azacitidine and venetoclax in patients with acute myelogenous leukemia (AML). The Phase 1b dose-escalation stage has...

Read more

Gluco OFF Reviewed: Don't Buy GlucoOff Blood Health Support Gummies Without Reading This Latest Report First!

April 25, 2026 3:20 PM

Disclosure: This is sponsored content published for informational purposes. It contains affiliate links. A commission may be earned if you purchase through those links, at no additional cost to you. This does not influence the accuracy or integrity of what you read here. Gluco OFF is a dietary supplement, not a medication. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose,...

Read more

Alpha Honey Gummies Reviewed: Don't Buy Alpha Honey Male Performance Gummies Before Reading This First!

April 25, 2026 2:20 PM

Affiliate Disclosure: This article contains affiliate links. If you purchase through links in this article, a commission may be earned at no additional cost to you. This does not influence the accuracy or integrity of the information presented. This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement. Supplements are not intended...

Read more

Federal Judge to Decide Whether Medicare Can Distribute Hemp-Marijuana Cannabinoids Without FDA Approval

April 25, 2026 12:45 PM

The case, Smart Approaches to Marijuana et al. v. Kennedy, Civil Action No. 26-1081 (TNM), is pending before U.S. District Judge Trevor N. McFadden. Plaintiffs filed a reply brief on April 24, 2026, responding to the government's motion to dismiss and opposition to preliminary injunctive relief. The reply brief, authored by constitutional litigator Ilya Shapiro of Burke Law Group, PLLC, lays out what plaintiffs describe as a straightforward...

Read more

Group Seeking Court Order to Halt CMS Medicare THC Hemp Marijuana Program

April 25, 2026 6:20 AM

A significant new filing submitted today in the U.S. District Court for the District of Columbia seeks an immediate injunction blocking the Centers for Medicare & Medicaid Services' controversial Substance Access Beneficiary Engagement Incentive (BEI) program, arguing the agency unlawfully created the first federal pathway allowing cannabinoid consumer products into Medicare without FDA approval or public rule making procedures. The filing,...

Read more

Elite Pro Force Reviewed: Don't Buy Elite Pro Force Male Gummies Before Reading This Report First!

April 24, 2026 9:20 PM

Disclaimers: This article is paid promotional content and may contain affiliate links. The publisher may receive compensation if readers purchase through links in this article. This compensation does not influence editorial integrity. This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement. Dietary supplements are not intended to...

Read more

LighthouseAI Raises $8 Million Series A

April 24, 2026 2:45 PM

LighthouseAI, the central intelligence and management platform for pharmaceutical state licensing and compliance, today announced the close of an $8 million Series A financing round. The round was led by Boxcars Ventures, with participation from TGVP and existing investors. The company has doubled its customer base since January 2025 and now serves 250 customers across the pharmaceutical supply chain, including manufacturers, wholesale...

Read more

Dr. Alonso Martin Brings a Data-Driven Perspective on Longevity and Biological Age to The Marty Davis Show

April 24, 2026 2:00 PM

Dr. Alonso Martin, founder of BODYWELLE, recently appeared on The Marty Davis Show to explore the growing focus on longevity medicine, biological age, and personalized preventive care-an approach that is changing how many patients approach aging, healthspan, and long-term preventive care. Hosted by Miami business lawyer and entrepreneur Marty Davis, the episode examined why many individuals who appear "healthy" on routine lab work still...

Read more

Lance A. Slatton Joins CaregiverCompanion.ai as Official Brand Ambassador, Expanding Reach of Breakthrough AI Support for Family Caregivers

April 24, 2026 12:30 PM

CaregiverCompanion.ai, the free AI-powered platform created to support family caregivers, today announced that Lance A. Slatton, nationally known as "The Senior Care Influencer," has been named the company's Official Brand Ambassador. Founder and host of All Home Care Matters, the nation's leading caregiver-focused media platform and a trusted voice in long-term care, Slatton is widely respected throughout the healthcare and senior living...

Read more

Magicare Exits Stealth with $3.6M Pre-Seed to Build the Agentic Operating System for Post‑Acute Care

April 24, 2026 12:08 PM

Magicare.ai (formerly Exponential) today announced it is exiting stealth and has closed $3.6 million in pre-seed funding to scale a suite of AI agents purpose-built for post‑acute operators. Investors include leading operators and Mana Ventures, reflecting a shared thesis: the next generation of post‑acute software will not be another point solution - it will be an agentic operating system that runs complex workflows end-to-end with human...

Read more

MemoPryl Reviewed: Don't Buy MemoPryl Supplementation for Brain Health Before Reading This Latest Report First!

April 24, 2026 11:45 AM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you take prescription medications or have existing health conditions. Supplements are not intended to diagnose, treat, cure, or prevent any disease. This article contains affiliate links. If you make a purchase through these links, a commission...

Read more

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

April 24, 2026 9:21 AM

Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the pricing of its public offering made on a firm commitment basis with gross proceeds to the Company expected to be approximately $4.0 million, before deducting fees and other expenses payable by the Company. The offering consists of 2,962,963 shares of common stock and...

Read more

Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care

April 24, 2026 9:00 AM

Aetna®, a CVS Health® company (NYSE:CVS) announced research findings from the inaugural Aetna Provider Survey, a quarterly study that polls a representative sample of the U.S. provider market to better understand their perceptions, opportunities, and challenges today and into the future. This survey series is intended to solicit timely, objective feedback from the U.S. provider market so we can identify opportunities to change the provider-payer...

Read more

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)

April 24, 2026 9:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related diseases, today announced the successful closing of its previously announced acquisition of TELI Pharmaceuticals, Inc. ("TELI"). The transaction, which was approved by Telomir's shareholders at the Company's Annual Meeting held on March 23,...

Read more